CASCADIAN THERAPEUTICS INC's ticker is CASC and the CUSIP is 14740B606. A total of 90 filers reported holding CASCADIAN THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $33,539,000 | -9.5% | 9,064,575 | 0.0% | 1.39% | +6.9% |
| Q3 2017 | $37,074,000 | +10.1% | 9,064,575 | 0.0% | 1.30% | +6.0% |
| Q2 2017 | $33,675,000 | -10.3% | 9,064,575 | 0.0% | 1.22% | -6.1% |
| Q1 2017 | $37,527,000 | +386.0% | 9,064,575 | +405.9% | 1.30% | +325.1% |
| Q4 2016 | $7,722,000 | – | 1,791,666 | – | 0.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|